An electrocardiogram (ECG) is a non-invasive test used to check the heart's rhythm and electrical activity. ECG is often used alongside other tests to diagnose and monitor conditions affecting the heart. It is an integral part of the initial evaluation of a patient suspected of having a cardiac-related problem. Thus, there is an increasing demand for ECG monitors worldwide.
Market Dynamics:
Rise in burden of cardiovascular disease (CVDs), growing geriatric population, increasing demand for ECG for the diagnosis of cardiac diseases, and increasing adoption and demand for portable or technologically advanced ECG monitors are major factors expected to augment the growth of the global electrocardiograph market over the forecast period.
For instance, in April 2023, Icentia, a medical technology company, secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ambulatory, continuous electrocardiogram (ECG) monitoring solution, CardioSTAT. The wire-free and single-use CardioSTAT recorder is a flexible, lightweight, and showerproof device, which can be easily worn on the upper chest for the cardiac monitoring. CardioSTAT has the potential to provide up to 14 days of continuous ECG recording and analysis with a compliance rate of 99.9%.
Key features of the study:
- This report provides in-depth analysis of the global electrocardiograph market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global electrocardiograph market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Medtronic PLC, AliveCor, Schiller AG, GE Healthcare, Nihon Kohden Corporation, Koninklinje Philips NV, Hill-Rom Holdings Inc. (Welch Allyn), OSI Systems Inc. (Spacelabs Healthcare), and Mindray Medical International Limited, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global electrocardiograph market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global electrocardiograph market.
Detailed Segmentation:
- Global Electrocardiograph Market, By Product:
- Rest ECG Systems
- Stress ECG Systems
- Holter ECG Systems
- Event Recorders
- Other Products
- Global Electrocardiograph Market, By Technology:
- Portable ECG Systems
- Wireless ECG Systems
- Global Electrocardiograph Market, By Lead Type:
- Single Lead ECG
- 3-6 Lead ECG
- 12 Lead ECG
- Global Electrocardiograph Market, By End User:
- Home-based Users
- Hospitals
- Other End Users
- Global Electrocardiograph Market, By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles:
- Medtronic PLC
- AliveCor
- Schiller AG
- GE Healthcare
- Nihon Kohden Corporation
- Koninklinje Philips NV
- Hill-Rom Holdings Inc. (Welch Allyn)
- OSI Systems Inc. (Spacelabs Healthcare)
- Mindray Medical International Limited
